Search research articles
Contact Us
Filters
Showing results (141-150 of 289) with videos related to
Page
of 29
Sort By:
Journal of Translational Medicine
|
August 16, 2022
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
Marzia Del Re, Stefania Crucitta, Federico Paolieri, et al.
Journal of Global Oncology
|
September 28, 2018
Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry
Hideyuki Akaza, Giuseppe Procopio, Choosak Pripatnanont, et al.
Cancer
|
October 21, 2006
Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study
Emilio Bajetta, Giuseppe Procopio, Laura Catena, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 15, 2016
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study
Chiara Fiorentini, Martina Fragni, Paola Perego, et al.
Clinical Genitourinary Cancer
|
June 15, 2019
Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma
Giuseppe Procopio, Aristotelis Bamias, Manuela Schmidinger, et al.
Tumori
|
August 2, 2022
Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy
Nicola Nicolai, Sebastiano Nazzani, Antonio Tesone, et al.
Expert Review of Proteomics
|
March 1, 2014
Stratification of clear cell renal cell carcinoma by signaling pathway analysis
Mattia Cremona, Virginia Espina, Dario Caccia, et al.
Clinical Genitourinary Cancer
|
November 7, 2018
Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study
Cristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, et al.
Frontiers in Oncology
|
September 2, 2022
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
Giandomenico Roviello, Martina Catalano, Ugo De Giorgi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 14, 2025
Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study
Viktor Grünwald, Axel Bex, Sylvie Rottey, et al.
Page
of 29
Search research articles
Search
Showing results (141-150 of 289) with videos related to
Sort By:
Page
of 29
Journal of Translational Medicine
|
August 16, 2022
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
Marzia Del Re, Stefania Crucitta, Federico Paolieri, et al.
Journal of Global Oncology
|
September 28, 2018
Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry
Hideyuki Akaza, Giuseppe Procopio, Choosak Pripatnanont, et al.
Cancer
|
October 21, 2006
Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study
Emilio Bajetta, Giuseppe Procopio, Laura Catena, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 15, 2016
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study
Chiara Fiorentini, Martina Fragni, Paola Perego, et al.
Clinical Genitourinary Cancer
|
June 15, 2019
Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma
Giuseppe Procopio, Aristotelis Bamias, Manuela Schmidinger, et al.
Tumori
|
August 2, 2022
Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy
Nicola Nicolai, Sebastiano Nazzani, Antonio Tesone, et al.
Expert Review of Proteomics
|
March 1, 2014
Stratification of clear cell renal cell carcinoma by signaling pathway analysis
Mattia Cremona, Virginia Espina, Dario Caccia, et al.
Clinical Genitourinary Cancer
|
November 7, 2018
Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study
Cristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, et al.
Frontiers in Oncology
|
September 2, 2022
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
Giandomenico Roviello, Martina Catalano, Ugo De Giorgi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 14, 2025
Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study
Viktor Grünwald, Axel Bex, Sylvie Rottey, et al.
Page
of 29